A Subset of Interleukin-21+ Chemokine Receptor CCR9+ T Helper Cells Target Accessory Organs of the Digestive System in Autoimmunity

Immunity

Volumn 34, Issue 4, 2011, Pages 602-615

  McGuire, Helen M ^a,b   Vogelzang, Alexis ^a,b   Ma, Cindy S ^a,b   Hughes, William E ^a,b   Silveira, Pablo A ^a,b   Tangye, Stuart G ^a,b   Christ, Daniel ^a,b   Fulcher, David ^c   Falcone, Marika ^d   King, Cecile ^a,b  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

^d SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR9; INTERLEUKIN 21;

ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DIABETES MELLITUS; DIGESTIVE SYSTEM; FEMALE; FOLLICULAR LYMPHOMA; HELPER CELL; HUMAN; MOUSE; NONHUMAN; PANCREATITIS; PRIORITY JOURNAL; SALIVARY GLAND; SJOEGREN SYNDROME; TARGET CELL;

ANIMALS; AUTOIMMUNITY; B-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CELL SURVIVAL; DIABETES MELLITUS; FEMALE; HUMANS; INTERLEUKINS; ISLETS OF LANGERHANS; MICE; MICE, KNOCKOUT; RECEPTORS, CCR; RECEPTORS, INTERLEUKIN-21; SJOGREN'S SYNDROME; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 79954584830     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2011.01.021     Document Type: Article

References (56)

1. Astorri E., Bombardieri M., Gabba S., Peakman M., Pozzilli P., Pitzalis C. Evolution of ectopic lymphoid neogenesis and in situ autoantibody production in autoimmune nonobese diabetic mice: Cellular and molecular characterization of tertiary lymphoid structures in pancreatic islets. J. Immunol. 2010, 185:3359-3368.
2. Bach J.F., Mathis D. The NOD mouse. Res. Immunol. 1997, 148:285-286.
3. Bauquet A.T., Jin H., Paterson A.M., Mitsdoerffer M., Ho I.C., Sharpe A.H., Kuchroo V.K. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nat. Immunol. 2009, 10:167-175.
4. Campbell D.J., Butcher E.C. Rapid acquisition of tissue-specific homing phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues. J. Exp. Med. 2002, 195:135-141.
5. Christianson S.W., Shultz L.D., Leiter E.H. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes 1993, 42:44-55.
6. D'Alise A.M., Auyeung V., Feuerer M., Nishio J., Fontenot J., Benoist C., Mathis D. The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors. Proc. Natl. Acad. Sci. USA 2008, 105:19857-19862.
7. Datta S., Sarvetnick N.E. IL-21 limits peripheral lymphocyte numbers through T cell homeostatic mechanisms. PLoS ONE 2008, 3:e3118.
8. Dong C., Juedes A.E., Temann U.A., Shresta S., Allison J.P., Ruddle N.H., Flavell R.A. ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature 2001, 409:97-101.
9. Duhen T., Geiger R., Jarrossay D., Lanzavecchia A., Sallusto F. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat. Immunol. 2009, 10:857-863.
10. Elgueta R., Sepulveda F.E., Vilches F., Vargas L., Mora J.R., Bono M.R., Rosemblatt M. Imprinting of CCR9 on CD4 T cells requires IL-4 signaling on mesenteric lymph node dendritic cells. J. Immunol. 2008, 180:6501-6507.
11. Faveeuw C., Gagnerault M.-C., Lepault F. Isolation of leukocytes infiltrating the islets of Langerhans of diabetes-prone mice for flow cytometric analysis. J. Immunol. Methods 1995, 187:163-169.
12. Goillot E., Mutin M., Touraine J.L. Sialadenitis in nonobese diabetic mice: Transfer into syngeneic healthy neonates by splenic T lymphocytes. Clin. Immunol. Immunopathol. 1991, 59:462-473.
13. Graewin S.J., Kiely J.M., Lee K.H., Svatek C.L., Nakeeb A., Pitt H.A. Nonobese diabetic mice have diminished gallbladder motility and shortened crystal observation time. J. Gastrointest. Surg. 2004, 8:824-829. discussion 829-830.
14. Hänninen A., Jaakkola I., Jalkanen S. Mucosal addressin is required for the development of diabetes in nonobese diabetic mice. J. Immunol. 1998, 160:6018-6025.
15. Hawiger D., Tran E., Du W., Booth C.J., Wen L., Dong C., Flavell R.A. ICOS mediates the development of insulin-dependent diabetes mellitus in nonobese diabetic mice. J. Immunol. 2008, 180:3140-3147.
16. Herber D., Brown T.P., Liang S., Young D.A., Collins M., Dunussi-Joannopoulos K. IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression. J. Immunol. 2007, 178:3822-3830.
17. Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., Cua D.J., Littman D.R. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133.
18. Jaakkola I., Jalkanen S., Hänninen A. Diabetogenic T cells are primed both in pancreatic and gut-associated lymph nodes in NOD mice. Eur. J. Immunol. 2003, 33:3255-3264.
19. Jansen A., Voorbij H.A., Jeucken P.H., Bruining G.J., Hooijkaas H., Drexhage H.A. An immunohistochemical study on organized lymphoid cell infiltrates in fetal and neonatal pancreases. A comparison with similar infiltrates found in the pancreas of a diabetic infant. Autoimmunity 1993, 15:31-38.
20. Johnston R.J., Poholek A.C., DiToro D., Yusuf I., Eto D., Barnett B., Dent A.L., Craft J., Crotty S. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 2009, 325:1006-1010.
21. Kendall P.L., Yu G., Woodward E.J., Thomas J.W. Tertiary lymphoid structures in the pancreas promote selection of B lymphocytes in autoimmune diabetes. J. Immunol. 2007, 178:5643-5651.
22. King C., Ilic A., Koelsch K., Sarvetnick N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 2004, 117:265-277.
23. King C., Tangye S.G., Mackay C.R. T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu. Rev. Immunol. 2008, 26:741-766.
24. Koarada S., Wu Y., Fertig N., Sass D.A., Nalesnik M., Todd J.A., Lyons P.A., Fenyk-Melody J., Rainbow D.B., Wicker L.S., et al. Genetic control of autoimmunity: protection from diabetes, but spontaneous autoimmune biliary disease in a nonobese diabetic congenic strain. J. Immunol. 2004, 173:2315-2323.
25. Koenecke C., Förster R. CCR9 and inflammatory bowel disease. Expert Opin. Ther. Targets 2009, 13:297-306.
26. Kunkel E.J., Campbell D.J., Butcher E.C. Chemokines in lymphocyte trafficking and intestinal immunity. Microcirculation 2003, 10:313-323.
27. Kusam S., Toney L.M., Sato H., Dent A.L. Inhibition of Th2 differentiation and GATA-3 expression by BCL-6. J. Immunol. 2003, 170:2435-2441.
28. Lennon G.P., Bettini M., Burton A.R., Vincent E., Arnold P.Y., Santamaria P., Vignali D.A. T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event. Immunity 2009, 31:643-653.
29. Linterman M.A., Rigby R.J., Wong R.K., Yu D., Brink R., Cannons J.L., Schwartzberg P.L., Cook M.C., Walters G.D., Vinuesa C.G. Follicular helper T cells are required for systemic autoimmunity. J. Exp. Med. 2009, 206:561-576.
30. Lyons P.A., Armitage N., Argentina F., Denny P., Hill N.J., Lord C.J., Wilusz M.B., Peterson L.B., Wicker L.S., Todd J.A. Congenic mapping of the type 1 diabetes locus, Idd3, to a 780-kb region of mouse chromosome 3: Identification of a candidate segment of ancestral DNA by haplotype mapping. Genome Res. 2000, 10:446-453.
31. McGuire H.M., Vogelzang A., Hill N., Flodström-Tullberg M., Sprent J., King C. Loss of parity between IL-2 and IL-21 in the NOD Idd3 locus. Proc. Natl. Acad. Sci. USA 2009, 106:19438-19443.
32. Monteleone G., Sarra M., Pallone F. Interleukin-21 in T cell-mediated diseases. Discov. Med. 2009, 8:113-117.
33. Mora J.R., Bono M.R., Manjunath N., Weninger W., Cavanagh L.L., Rosemblatt M., Von Andrian U.H. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 2003, 424:88-93.
34. Nurieva R.I., Chung Y., Hwang D., Yang X.O., Kang H.S., Ma L., Wang Y.H., Watowich S.S., Jetten A.M., Tian Q., Dong C. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 2008, 29:138-149.
35. Nurieva R.I., Chung Y., Martinez G.J., Yang X.O., Tanaka S., Matskevitch T.D., Wang Y.H., Dong C. Bcl6 mediates the development of T follicular helper cells. Science 2009, 325:1001-1005.
36. Odegard J.M., Marks B.R., DiPlacido L.D., Poholek A.C., Kono D.H., Dong C., Flavell R.A., Craft J. ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity. J. Exp. Med. 2008, 205:2873-2886.
37. Ozaki K., Spolski R., Feng C.G., Qi C.F., Cheng J., Sher A., Morse H.C., Liu C., Schwartzberg P.L., Leonard W.J. A critical role for IL-21 in regulating immunoglobulin production. Science 2002, 298:1630-1634.
38. Pai S.Y., Truitt M.L., Ho I.C. GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells. Proc. Natl. Acad. Sci. USA 2004, 101:1993-1998.
39. Papadakis K.A., Prehn J., Nelson V., Cheng L., Binder S.W., Ponath P.D., Andrew D.P., Targan S.R. The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system. J. Immunol. 2000, 165:5069-5076.
40. Papadakis K.A., Landers C., Prehn J., Kouroumalis E.A., Moreno S.T., Gutierrez-Ramos J.C., Hodge M.R., Targan S.R. CC chemokine receptor 9 expression defines a subset of peripheral blood lymphocytes with mucosal T cell phenotype and Th1 or T-regulatory 1 cytokine profile. J. Immunol. 2003, 171:159-165.
41. Phillips J.M., Haskins K., Cooke A. MAdCAM-1 is needed for diabetes development mediated by the T cell clone, BDC-2.5. Immunology 2005, 116:525-531.
42. Reinhardt R.L., Liang H.E., Locksley R.M. Cytokine-secreting follicular T cells shape the antibody repertoire. Nat. Immunol. 2009, 10:385-393.
43. Serreze D.V., Chapman H.D., Varnum D.S., Hanson M.S., Reifsnyder P.C., Richard S.D., Fleming S.A., Leiter E.H., Shultz L.D. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: Analysis of a new " speed congenic" stock of NOD.Ig mu null mice. J. Exp. Med. 1996, 184:2049-2053.
44. Søndergaard H., Skak K. IL-21: Roles in immunopathology and cancer therapy. Tissue Antigens 2009, 74:467-479.
45. Spolski R., Leonard W.J. Interleukin-21: Basic biology and implications for cancer and autoimmunity. Annu. Rev. Immunol. 2008, 26:57-79.
46. Spolski R., Kashyap M., Robinson C., Yu Z., Leonard W.J. IL-21 signaling is critical for the development of type I diabetes in the NOD mouse. Proc. Natl. Acad. Sci. USA 2008, 105:14028-14033.
47. Suto A., Kashiwakuma D., Kagami S.I., Hirose K., Watanabe N., Yokote K., Saito Y., Nakayama T., Grusby M.J., Iwamoto I., Nakajima H. Development and characterization of IL-21-producing CD4+ T cells. J. Exp. Med. 2008, 205:1369-1379.
48. Trifari S., Kaplan C.D., Tran E.H., Crellin N.K., Spits H. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat. Immunol. 2009, 10:864-871.
49. Vaarala O. The gut immune system and type 1 diabetes. Ann. N Y Acad. Sci. 2002, 958:39-46.
50. Vicari A.P., Figueroa D.J., Hedrick J.A., Foster J.S., Singh K.P., Menon S., Copeland N.G., Gilbert D.J., Jenkins N.A., Bacon K.B., Zlotnik A. TECK: A novel CC chemokine specifically expressed by thymic dendritic cells and potentially involved in T cell development. Immunity 1997, 7:291-301.
51. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., Daniels T.E., Fox P.C., Fox R.I., Kassan S.S., et al. Classification criteria for Sjögren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 2002, 61:554-558. European Study Group on Classification Criteria for Sjögren's Syndrome.
52. Vogelzang A., McGuire H.M., Yu D., Sprent J., Mackay C.R., King C. A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity 2008, 29:127-137.
53. Wei G., Wei L., Zhu J., Zang C., Hu-Li J., Yao Z., Cui K., Kanno Y., Roh T.Y., Watford W.T., et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 2009, 30:155-167.
54. Wicker L.S., Leiter E.H., Todd J.A., Renjilian R.J., Peterson E., Fischer P.A., Podolin P.L., Zijlstra M., Jaenisch R., Peterson L.B. Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes 1994, 43:500-504.
55. Wurbel M.A., Philippe J.M., Nguyen C., Victorero G., Freeman T., Wooding P., Miazek A., Mattei M.G., Malissen M., Jordan B.R., et al. The chemokine TECK is expressed by thymic and intestinal epithelial cells and attracts double- and single-positive thymocytes expressing the TECK receptor CCR9. Eur. J. Immunol. 2000, 30:262-271.
56. Yu D., Rao S., Tsai L.M., Lee S.K., He Y., Sutcliffe E.L., Srivastava M., Linterman M., Zheng L., Simpson N., et al. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity 2009, 31:457-468.